Avita Medical | 1811094D - 销售成本



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 144.84M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


销售成本 更改 日
Accuray USD 116.17M 14.63M 2024-12
Celltrion KRW 107.42B 295.44B 2025-12
Clinuvel Pharmaceuticals AUD 2.64M 1.06M 2025-12
Cochlear AUD 319.2M 160.35M 2025-12
CSL USD 3.87B 2.08B 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 12.39B 1.76B 2026-03
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Mayne Pharma AUD 43.74M 2.67M 2024-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Nanosonics AUD 24.22M 1.11M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 56.93M 20.53M 2025-12
Pacific Edge NZD 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Pharma Mar EUR 3.66M 116K 2026-03
Polynovo AUD 9.02M 3.51M 2025-12
Qiagen NV USD 217.43M 29.65M 2025-12
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 536.28M 21.52M 2025-12
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Telix Pharmaceuticals AUD 221.36M 20.78M 2025-12
Tilray USD 164.37M 8.41M 2025-09
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03